EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study

Desirée Martín-García, Marilina García-Aranda, Esperanza Varela-Moreno, María Padilla-Ruiz, Irene Zarcos-Pedrinaci, Francisco Rivas-Ruiz, Teresa Téllez, Susana García-Gutiérrez, Nerea González, Amado Rivero, Cristina Sarasqueta, Lilisbeth Perestelo-Pérez und 5 weitere

European Journal of Surgical Oncology · 2025-08 · 51 (8) · 110280

DOI: 10.1016/j.ejso.2025.110280 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025-08. Verfasst von Desirée Martín-García und 16 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Specialties, Biochemistry and Immunology Department, Faculty of Medicine, University of Málaga, 29010, Málaga, Spain; Red de Investigación e…. Hauptthemen laut MEDLINE: Breast Neoplasms, Delayed Diagnosis, Time-to-Treatment. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Regional Development Fund, Carlos III Health Institute, European Social Fund Plus.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Delays in the diagnosis and treatment of breast cancer can be attributed to sociodemographic characteristics, clinical-pathological factors, and the functioning of the health system. This study aims to examine the impact of patient-attributable delay (PPAD) on timely medical care and its effect on patient survival. METHODS: This multicenter, prospective, observational study included 543 patients diagnosed with breast cancer between 2013 and 2015. A PPAD was defined as a delay of more than 90 days between symptom onset and consultation with a primary care physician or emergency department. The rate of PPAD in this population was 14.18 %. RESULTS: Segmented analysis revealed significant associations with age and living alone, with living alone emerging as the only independent predictor of PPAD (Odds Ratio OR: 1.882; 95 % Confidence Interval CI: 1.033-3.42). Significant associations were identified between clinical stage (p < 0.001), immunophenotype (p < 0.001), PPAD (p < 0.05), age (p < 0.001), household situation (p < 0.001) and body mass index (p < 0.05) with breast cancer prognosis. In the multivariate analysis, PPAD was an independent risk factor for two-year mortality (OR 3.08; 95 % CI 1.05-9.07), second only to clinical stage (OR 6.78; 95 % CI 2.51-18.3). Age also remained as a significant predictor (OR 1.04; 95 % CI 1.01-1.07). CONCLUSION: Our findings highlight the need for targeted interventions to raise cancer symptom awareness and address barriers faced by vulnerable groups, such as the elderly and individuals living alone, to reduce delays, improve clinical outcomes, increase survival rates, and ultimately the quality of life for patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsDelayed DiagnosisTime-to-TreatmentHumansFemaleProspective StudiesMiddle AgedAgedAdultSurvival RateAge FactorsNeoplasm StagingAged, 80 and overTime Factors

Stichwörter der Autor:innen

Breast cancerCancer awarenessDiagnosis delayPatient-attributable delay (PPAD)PrognosisSurvival

Autor:innen und Institutionen

  • Surgical Specialties, Biochemistry and Immunology Department, Faculty of Medicine, University of Málaga, 29010, Málaga, Spain; Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Mad…
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain; Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina - IBIMA Plataforma BIONAND, 29590, Mála…
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain; Research and Innovation Unit. Hospital Universitario Costa del Sol, 29602, Marbella, Spain; Red de Investigación en…
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain; Medical Oncology Dep…
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain; Research Unit, Galda…
  • Red de Investigación en Cronicidad, Atención Primaria y Promoción de la Salud (RICAPPS), Madrid, Spain; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, Spain; Canary Islands Found…

Förderung

  • European Regional Development Fund
  • Carlos III Health Institute
  • European Social Fund Plus
  • Consejería de Salud y Familias, Junta de Andalucía
  • Universidad de Málaga

Zitieren

APA

Martín-García, D., García-Aranda, M., Varela-Moreno, E., Padilla-Ruiz, M., Zarcos-Pedrinaci, I., Rivas-Ruiz, F., Téllez, T., García-Gutiérrez, S., González, N., Rivero, A., Sarasqueta, C., Perestelo-Pérez, L., Castells, X., Quintana, J. M., Sala, M., Redondo, M., & REDISSEC/CAMISS Group (2025). Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study. European Journal of Surgical Oncology, 51(8), 110280. https://doi.org/10.1016/j.ejso.2025.110280

Vancouver

Martín-García D, García-Aranda M, Varela-Moreno E, Padilla-Ruiz M, Zarcos-Pedrinaci I, Rivas-Ruiz F, et al. Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study. European Journal of Surgical Oncology. 2025;51(8):110280. doi:10.1016/j.ejso.2025.110280

BibTeX
@article{MartnGarca2025,
  author = {Martín-García, Desirée and García-Aranda, Marilina and Varela-Moreno, Esperanza and Padilla-Ruiz, María and Zarcos-Pedrinaci, Irene and Rivas-Ruiz, Francisco and Téllez, Teresa and García-Gutiérrez, Susana and González, Nerea and Rivero, Amado and Sarasqueta, Cristina and Perestelo-Pérez, Lilisbeth and Castells, Xavier and Quintana, José María and Sala, María and Redondo, Maximino and REDISSEC/CAMISS Group, REDISSEC/CAMISS Group},
  title = {Patient-attributable delay and its impact on two-year survival in breast cancer: A multicenter prospective cohort study},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  volume = {51},
  number = {8},
  pages = {110280},
  doi = {10.1016/j.ejso.2025.110280}
}
Kostenlos starten →